FRA:NXU • DE0005220909
Overall NXU gets a fundamental rating of 7 out of 10. We evaluated NXU against 11 industry peers in the Health Care Technology industry. NXU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NXU is valued quite expensive, but it does show an excellent growth. These ratings could make NXU a good candidate for growth and quality investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| ROIC | 8.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.41% | ||
| PM (TTM) | 12.11% | ||
| GM | 84.7% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.34 | ||
| Altman-Z | 5.57 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.14 | ||
| Fwd PE | 32.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.76 | ||
| EV/EBITDA | 16.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
FRA:NXU (11/24/2025, 7:00:00 PM)
71.2
-0.1 (-0.14%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.14 | ||
| Fwd PE | 32.24 | ||
| P/S | 4.39 | ||
| P/FCF | 21.76 | ||
| P/OCF | 18.33 | ||
| P/B | 4.08 | ||
| P/tB | 17.79 | ||
| EV/EBITDA | 16.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| ROCE | 11.14% | ||
| ROIC | 8.35% | ||
| ROICexc | 12.84% | ||
| ROICexgc | 162.09% | ||
| OM | 15.41% | ||
| PM (TTM) | 12.11% | ||
| GM | 84.7% | ||
| FCFM | 20.15% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.34 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 53.69% | ||
| Cap/Sales | 3.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.6% | ||
| Profit Quality | 166.39% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.08 | ||
| Altman-Z | 5.57 |
ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE.
ChartMill assigns a valuation rating of 3 / 10 to NEXUS AG (NXU.DE). This can be considered as Overvalued.
NEXUS AG (NXU.DE) has a profitability rating of 7 / 10.
The financial health rating of NEXUS AG (NXU.DE) is 8 / 10.
The Earnings per Share (EPS) of NEXUS AG (NXU.DE) is expected to grow by 14.6% in the next year.